There are 2 important areas for improvement in the clinical care of sickle cell stroke. For acute ischemic stroke therapy, the 2014 National Institutes of Health guideline recommends exchange transfusions without mentioning thrombolysis, despite its benefits in general ischemic stroke. However, a recent report showed that coexistent sickle cell disease does not increase the incidence of tPA (tissue-type plasminogen activator)-induced cerebral hemorrhage.
S
troke is a common and severe complication of sickle cell anemia (SCA). 1 Without preventive treatment, as many as 37% of SCA children develop silent cerebral infarct (SCI) by age 14, and 11% show large overt stroke before age 20. [1] [2] [3] Overt stroke is often associated with intimal lesions in the carotid arteries, which manifest as obstructions on magnetic resonance angiography or accelerated blood flow in the transcranial Doppler measurement. [4] [5] [6] [7] In contrast, SCI is diagnosed by magnetic resonance imaging in patients with SCA who lack clear symptoms but often have a history of transient ischemic episodes or cognitive impairment. 2, 3 SCI and overt stroke may share similar pathological underpinnings or could be precipitated by different severities of hypoxia, ischemia, anemia, or infection.
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December 2017 lesions in the carotid arteries similar to SCA patients. Past studies indicated that sickle mice develop enhanced clot formation and larger infarcts after photoactivated thrombosis, but their responses to lytic therapy are unknown. [12] [13] [14] In this study, we examined blood flow and pulse waveforms in the carotid artery of sickle mice and tested their responses to 2 versions of subthreshold hypoxia-ischemia (HI) insult at 3 and 6 months of age, respectively. The advantage of the HI model is that its trigger, dual HI, is relevant to the pathophysiology of SCA stroke. 3 Moreover, because tPA treatment confers protection of transient HI (tHI) in wild-type mice, 15, 16 we can use this stroke model to assess the risks and benefits of thrombolytic therapy in sickle mice. Our results suggest that sickle mice are more sensitive to HI-induced stroke but benefit from acute tPA therapy. Finally, elevated resistive index (RI) may be an earlier ultrasonic marker of sickle cell vasculopathy than increased flow velocity.
Materials and Methods
The authors are pleased to share detailed analytic methods and data with researchers on request. All study materials in this study are available through commercial vendors.
Animal Surgery and Treatment
Sickle mice were obtained from Jackson Laboratories (stock No. 013071), and complete blood counts were measured by a Hemavet 1500 blood analyzer (CDC Technologies, Oxford, CT). Three-monthold male non-sickle (AA) and sickle cell (SS) mice were subjected to repetitive mild HI (rmHI) or tHI, as described previously with minor modifications. 15, 16 For rmHI, mice were anesthetized under 2% isoflurane for permanent right common carotid artery occlusion (RCCAO) with a 4.0 silk suture. The animal core temperature was maintained at 37.5±0.5°C. After RCCAO, mice were subjected to 15 minutes of hypoxia (7.5% O 2 /92.5% N 2 ) each day for 3 consecutive days. For tHI, 6-month-old male AA, sickle cell trait (AS), and SS mice were anesthetized by 2% isoflurane to undergo transient RCCAO with 2 releasable knots of 4.0 silk sutures and exposed to hypoxia (7.5% O2 and 92.5% N2) via a face mask for 20 minutes, while the core temperature was maintained at 37.5±0.5°C. After hypoxia, the knots on the right common carotid arteries were released. In wild-type mice, 20 minutes of tHI insult rarely induces cerebral infarction, and so we refer this insult in this study as subthreshold. Recombinant human tPA (10 mg/kg; Activase; Genetech, San Francisco) was injected via the tail vein at 30 minutes after tHI insult (50% as a bolus and 50% infused for 30 minutes). The surgical procedures in this study were approved by the Institutional Animal Care and Use Committee and conform to the National Institutes of Health Guide for Care and Use of Laboratory Animals.
Ultrasound Imaging
Ultrasound imaging was performed using the Vevo 2100 ultrasound imaging system with a MS-550D probe (FUJIFILM VisualSonics, Toronto, Canada). 17 Animals were anesthetized using 2% isoflurane and positioned supine on the heating pad with a heart rate monitor. All images, including B-mode imaging, for anatomy and doppler measurement of blood flow in the common carotid artery and bifurcation were obtained. The peak systolic velocity (PSV) and the RI ([PSV−end diastolic velocity]/PSV) 18 of common carotid arteries were calculated using the Vevo LABORATORY Workstation software.
Assessment of Cerebral Infarction
Identification of brain infarcts was performed by in vivo 2,3,5-triphenyltetrazolium chloride staining 24 hours after tHI or rmHI by a laboratory member blind to the mouse genotype. Brains were sectioned to 0.7-mm thick slices (8 per brain) and analyzed with the ImageJ 1.4 software (NIH, Bethesda, MD). The infarct size was quantified as the ratio of the infarcted area to the area in contralateral hemisphere.
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Immunohistochemistry and Immunoblotting Analysis
Immunohistochemistry and immunoblotting were performed as described previously. 20 Semiquantification of immunohistochemistry was performed using the CellSens software (Olympus). The same contrast and threshold criteria were applied to all images to obtain the total intensity of positive staining signals. The value of intensity was normalized to the AA group. The following antibodies were used: rabbit antifibrinogen (a gift of Dr Jay Degen), rabbit anti-GFAP ( 
Intravital Fluorescence Imaging
Wild-type (C57BL/6), AA, and SS mice were subjected to 20-minute tHI insults, followed by intravital imaging of cerebral vessel at 4-hour recovery, as reported previously. 12 Briefly, platelets (1×10 8 ) were isolated from a wild-type mouse and stained with 90 µmol/L carboxyfluorescein succinimidyl ester, followed by tail vein injection 5 minutes before intravital imaging. Circulating leukocytes were further labeled by 0.02% rhodamine 6G in continuous infusion. Fluorescently labeled leukocytes and platelets were visualized on an inverted microscope (AX70; Olympus, Tokyo, Japan). Intravital images were randomly selected to capture 20 frames per minute for 2 minutes by a CCD camera (CoolSNAP HQ2; Photometrics, Tucson, AZ) and analyzed with the MetaMorph image software. Adherent cells were defined as having a stationary interaction on the venular wall for >3 seconds.
Histological Assay of Vascular Obstruction
Vascular perfusion and blood-brain barrier leakage were evaluated by Evans blue albumin as described. 15 Briefly, mice received tail vein injection of 200-μL 2% Evans blue solution at 4 hours after tHI. After 10 minutes for the Evans blue dye circulation, mice were euthanized, and the brains were quickly placed in 4% paraformaldehyde. Fixed brains were sectioned at 100 μm, and the fluorescence was observed using a 680-nm emission filter on microscope (BX43; Olympus, Tokyo, Japan).
Statistical Analysis
Statistical analysis was performed using 1-way ANOVA followed by the Newman-Keuls test or unpaired t test for 2 samples (GraphPad Prism software; La Jolla, CA). The mortality analysis in rmHI was performed using the Kaplan-Meier method. The P values of survival rate comparisons in tHI were determined using the contingency table and χ 2 test. P values <0.05 were considered a significant difference. All values were expressed as mean±SEM.
Results
Sickle Mice Are More Sensitive to rmHI-Induced Cerebral Infarct
Townes sickle mice complete the fetal-to-adult hemoglobin switch around postnatal day 21.
21 By 3 months of age, male SS mice showed a lower blood hemoglobin level (9.0±0.31 g/dL; n=6) than AA (11.3±0.1 g/dL; n=5) and AS mice (12.8±0.2 g/dL; n=6). Doppler ultrasound revealed a higher RI but normal mean velocity (MV) and PSV in the carotid artery in SS than AA and AS mice (n=5-6 for each genotype; Figure 1A ). The greater RI in SS mice, shown as a deeper PSV-to-end diastolic velocity drop in pulse waveforms ( Figure 1B ), suggests greater resistance to blood flow in the cerebral microvascular bed. 18 To simulate the chronic circulatory insults in SCI (hypoxia and ischemia confronted with anemia), 3 we subjected 3-month-old male AA and SS mice to rmHI that consists of unilateral RCCAO and daily 15 minutes exposure to 7.5% oxygen for 3 days. No AA mice died from the rmHI insult (n=9), although SS mice showed the cumulative death rate of 20% after the first episode of hypoxia, 50% after the second episode, and 60% after the third episode of hypoxia and without further death for 3 days (n=10; Figure 1C ). The surviving SS mice on day 7 exhibited larger cerebral infarct than AA mice (14% versus 5.7% of contralateral hemisphere; P=0.031 by t test; Figure 1C ). In contrast, neither ischemia (RCCAO) nor hypoxia (daily exposure to 15 minutes hypoxia for 3 days) triggered mortality or cerebral infarct in either AA or SS mice (n=3 for each genotype challenge; Figure 1C ). These results suggest unique pathological effects of combined HI on sickle mice. Immunostaining showed greater fibrin(ogen) deposition and GFAP-positive astrogliosis in the ipsilateral hemisphere of surviving SS mice but not in the contralateral hemisphere or rmHI-injured AA mouse brains (the immunostaining intensity was quantified for comparison with t test; n=4 for each genotype; Figure 1D ). We also examined the response to 1 episode of 20-minute tHI but found no mortality or cerebral infarct in either AA or SS mice (data not shown). These results suggest that 3-month-old SS mice already develop a higher sensitivity to rmHI-induced cerebral infarct and mortality, correlated with an elevated RI in the carotid artery.
Sickle Mice Show Procoagulant but Not Proliferative-Obstructive Vasculopathy
To test whether older sickle mice develop accelerated carotid blood flow like SCA patients at risk for overt stroke, 6 we compared the carotid artery flow velocity and pulse waveforms in 6-month-old male sickle and control mice. At this age, SS mice retained a similar degree of anemia to 3-month-old mice (hemoglobin, 9.47 compared with 12 g/ dL in AA and AS mice) but developed a greater MV, PSV, and RI than AA mice (n=7 for AA and n=9 for SS mice; Figure 2A ). AS mice showed higher MV than AA mice but lower RI than SS mice (n=8 for AS mice; Figure 2A ). The increased RI was also shown as a deeper PSV-to-end diastolic velocity drop in 6-month-old SS mice ( Figure 2B ). Thus, 6-month-old SS mice developed greater flow velocity and persistently elevated RI, despite a similar degree of anemia to 3-month-old mice, Significantly increased transcranial Doppler flow velocity in SCA patients (>200 cm/s) is considered a sign of largevessel obstructive vasculopathy, including duplication of the internal elastic membrane and expansion of the smooth muscle ring.
4-6 Surprisingly, we found no differences in the elastic laminae and smooth muscle actin expression in the carotid artery between 6-month-old AA, AS, and SS mice (immunostaining signals were quantified and compared by t test; n=3 for each genotype; Figure 2C ). Neither was there evidence for intimal hypertrophy in SS mice. Instead, the cerebral blood vessel wall showed ectopic expression of P-selectin and PAI-1 (plasminogen activator inhibitor-1), correlated with positive PAI-1 signals in SS mouse brains by immunoblot (immunostaining signals were quantified and compared by t test; n=3 for each genotype; Figure 2D ). These results, similar to the reports of ectopic P-selectin and PAI-1 expression in the pulmonary endothelium, 13, 22 suggest a proadhesive, procoagulant endothelial phenotype in sickle mice.
Sickle Mice Are Sensitive to Hypoxia/IschemiaInduced Leukocyte and Platelet Aggregation
To test the procoagulant propensity in SS mice, we used intravital microscopy to compare the flow of leukocytes (labeled by rhodamine 6G) and platelets (labeled by carboxyfluorescein succinimidyl ester) in the cerebral blood vessels in 3-monthold AA and SS mice. 12 This analysis showed more leukocytes, but not platelets, adhered to the cerebral venular wall in the absence of insult in SS mice (the attached leukocytes and platelets are indicated by arrows; P value is determined by t test; n=3-4 for each genotype; Figure 3A ; Movies I through VI in the online-only Data Supplement). These results suggest a baseline of enhanced leukocyte-endothelium interaction in the SS mouse brains.
Next, we compared the flow of leukocytes and platelets at 4 hours after 20-minute tHI insult in 6-month-old AA and SS mice. At 4 hours post-tHI, platelets and leukocytes flowed smoothly in cerebral blood vessels in AA mice ( Figure 3B ). In contrast, leukocytes and platelets showed a sluggish flow or aggregates in the venules of ipsilateral hemisphere in SS mice ( Figure 3B ; Movies VII through XII in the online-only Data Supplement; aggregates are indicated by arrowheads). No aggregates of leukocytes or platelets were found on the contralateral hemisphere of SS mice at 4 hours after 20-minute tHI insult (data not shown). Quantification confirmed more leukocytes and platelets adhered to the cerebral venular wall at 4 hours after 20-minute tHI in the SS than AA mice (P=0.0004 and 0.0083, respectively; Figure 3B ; n=3 for each genotype). These data suggest that sickle mice have a higher sensitivity to tHI-induced platelet and leukocyte aggregation.
SS Mice Are More Sensitive to tHI-Induced Mortality and Infarct but Respond to tPA Therapy
To assess the consequences of tHI-induced platelet and leukocyte aggregation, we used fibrin(ogen) immunostaining and intravenous Evans blue dye injection to compare thrombosis and vascular perfusion, respectively, at 4 hours after 20 minute-tHI between 6-month-old AA and SS mice. This analysis showed greater fibrin deposition and reduction of vascular perfusion in the ipsilateral cortex in SS mice but not in contralateral cortex or tHI-challenged AA mouse brains (Figure 4A and 4B; shown are representative results in n=3 for each condition). Interestingly, intravenous tPA treatment at 0.5 hours post-tHI reduced fibrin deposition and improved vascular perfusion in SS mice ( Figure 4B ; P<0.05 by 1-way ANOVA; n=3 for each genotype). These results suggest that tPA treatment attenuates thrombotic brain injury in SS mice.
Moreover, 20-minute tHI caused significantly greater mortality in 6-month-old SS mice (27% survival at 24-hour recovery;
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December 2017 Red arrows are the direction of blood flow toward the transducer, whereas blue arrows flow away from the transducer. C, SS mice showed an accumulated death rate of 20% at day 2, 50% at day 3, and 60% from day 4 till day 7 after unilateral right common carotid artery occlusion (RCCAO) and daily exposure to 15-minute hypoxia for 3 consecutive days (n=10). In contrast, no AA mice died after repetitive mild HI (rmHI) insult (n=9). Furthermore, neither RCCAO nor daily exposure to 15-minute hypoxia for 3 days caused mortality or cerebral infarction in SS (n=3 for each condition) or AA mice (data not shown). The SS mice that survived rmHI injury showed larger infarct than AA mice by TTC stain (AA, 5.75±1.45%; SS, 14.03±3.27%). Shown are the mean±SEM. P values were determined by unpaired t test. D, The SS mice that survived rmHI also showed greater fibrin(ogen) deposition and GFAP (glial fibrillary acidic protein) immunoreactivity than AA mice (n=4 for SS and AA mice). The intensity of immunostaining was quantified and compared by t test. Scale bar: 100 μm. EDV indicates end-diastolic velocity. AA indicates non-sickle; AS, sickle cell trait; GFAP, glial fibrillary acidic protein; NS, non-significant; and SS, sickle cell. Figure 4C ). In contrast, the survival rate was more than doubled to 69% in SS mice that received tPA at 0.5 hours post-tHI, (n=13; P=0.04 compared with vehicle-treated SS mice), although still lower than that in AA mice (P=0.02 by χ 2 test). No obvious infarction was noted in the brains of surviving mice in either genotype. Although cerebral infarct may not be the only cause of tHI-induced mortality in SS mice, these results suggest that thrombolysis protects SS mice against transient hypoxic-ischemic injury.
Discussion
Humanized sickle mice are important tools for the development of many novel treatments of SCA, including the prevention of pain crises with anti-P-selectin antibody (crizanlizumab) and the prolongation of SS red blood cell half-life by GBT-440. 23, 24 However, there are few stroke models in sickle mice. [12] [13] [14] Our results suggest 2 stroke models based on hypoxic-ischemic insults in sickle mice that may relate to SCA patients, in whom the same insult often leads to an imbalance of oxygen consumption and oxygen delivery in the brain. [1] [2] [3] We showed that 3-month-old SS mice already developed a higher sensitivity to repetitive mild hypoxia in the face of unilateral flow restriction because of carotid ligation (the rmHI model), leading to higher mortality and larger cerebral infarct. In contrast, neither unilateral carotid ligation nor repeated exposures to hypoxia caused cerebral infarct in 3-month-old SS mice, suggesting unique pathogenic effects of combined HI. By 6 months of age, SS mice exhibited greater perfusion defects, fibrin deposition, and higher mortality in Continued. elastic membrane (green) and anti-smooth muscle actin labeling (SMA; red), counterstained by 4',6-diamidino-2-phenylindole (blue; n=3 for each genotype). The immunostaining intensity was quantified and compared by t test. Note that SS mice showed no evidence of duplication-interruption of the internal elastic lamina or hypertrophy of perivascular smooth muscle that was detected in sickle cell anemia patients with overt stroke. 4 ,5 D, Immunofluorescence labeling showed ectopic P-selectin (a marker for endothelial activation) and PAI-1 (plasminogen activator inhibitor-1) expression in the cerebral blood vessel wall of SS mice but not in AA or AS mice (n=3 for each genotype). The intensity of immunostaining was quantified for comparison by t test. Likewise, immunoblotting showed consistent anti-PAI-1 signals in SS but not AA or AS mouse brains. Shown in immunoblot are 3 mice for each genotype. Scale bar: 40 μm in (C) and 50 μm in (D). AA indicates non-sickle; AS, sickle cell trait; DAPI, 4',6-diamidino-2-phenylindole; NS, non-significant; and SS, sickle cell.
response to transient hypoxic-ischemic insult (the tHI model) than AA mice. These 2 models may facilitate mechanistic and therapeutic studies of sickle cell stroke.
Interestingly, only increased RI, but not greater PSV or MV, was developed in the carotid artery of 3-month-old SS mice with a higher sensitivity to rmHI-induced mortality and cerebral infarct. By 6 months of age, the RI remained elevated, but SS mice also developed greater PSV and MV similar to the flow alterations in SCA patients at higher risk for stroke. The differences in flow velocities between 3 and 6 months in SS mice were not because of progressive anemia because the hemoglobin levels at these 2 ages were similar. Of note, RI is determined by the resistance in the distal microvascular bed but attenuated by the stiffness of the large input vessel. 18 Thus, RI may manifest biphasic changes with an initial rise because of the increasing downstream resistance and a secondary decline secondary to stenosis of the input vessel. 18 There are several potential factors for a greater carotid RI in SCA, including impaired SS red blood cell deformability, the opening of small arterioles to increase the basal cerebral blood flow, and enhanced blood cellendothelium adhesion. 25 Given that only elevated RI was associated with sensitivity to rmHI-induced infarct in 3-month-old SS mice, our results suggest that RI is a more sensitive indicator of stroke propensity in SCA than the flow velocity.
Interestingly, greater RI has been used as a marker of vasculopathy in other clinical contexts. In obstetrics, high RI in the umbilical artery is an accepted marker of intrauterine growth restriction because of placental vasculopathy. 26 Greater RI in renal Doppler sonography in SCA patients is also used as an early sign of renovascular pathologies. 27 Yet, reduction of RI in the ophthalmic artery was suggested to indicate high risk for overt stroke in SCA patients. 28 The STOP trial (Stroke Prevention Trial in Sickle Cell Anemia) did not include RI as a criterion to assess the stroke risk, but extremely dampened Sickle cell (SS) mice are hypersensitive to tHI-induced blood clotting and mortality but respond to the tPA (tissue-type plasminogen activator) treatment. A, Challenged by a subthreshold (20 minutes) tHI insult, 6-month-old SS mice showed impaired distribution of tail veininjected Evans blue (EB) dye, correlated with more intense fibrin(ogen) deposition in the ipsilateral hemisphere at 4 hours recovery compared with contralateral hemisphere and tHI-challenged AA mouse brains (n=3 for each). In contrast, the SS mice that received intravenous tPA treatment (10 mg/kg, 50% as bolus and 50% as infusion for 30 minutes at 0.5 hours post-tHI) exhibited minimal fibrin(ogen) deposition and improved cerebral vascular perfusion (n=3). Scale bar: 200 μm. B, Comparison of cerebrovascular perfusion using the EB dye fluorescence quantified by 1-way ANOVA and Newman-Keuls post hoc test. NS: P>0.05. C, At 24 hours after 20-minute tHI insult, the survival rate in AA mice was 96% (23 of 24), 87% in sickle cell trait (AS) mice (7 of 8), 27% in vehicle-treated SS mice (3 of 11), and 69% in tPA-treated SS mice (9 of 13). No obvious infarction was noted in the brains of surviving mice in either genotype. Using the survival rate in AA mice as the expectancy, the survival rates in AS and tPA-treated SS mice were comparable (NS; by χ 2 test), but vehicle-treated SS mice showed significant reduction of survival (P<0.0001). Moreover, the tPA-treated SS mice showed improved survival than vehicle-treated SS mice (P=0.04), although still less than AA mice (P=0.02). D, Our data suggest the progression from procoagulant to obstructive vasculopathy in sickle cell anemia and different precipitating conditions for silent cerebral infarct and large overt stroke. AA indicates non-sickle; AS, sickle cell trait; and SS, sickle cell.
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Doppler waveforms with decreased flow velocity (therefore, low RI) was considered a sign of severe stenosis of cerebral vessels, a late stage vasculopathy in SCA. 7 In light of our results showing that increased carotid artery RI in young SS mice signifies higher sensitivity to HI-induced cerebral infarct, future studies are warranted to compare the progression of elevated RI and flow velocity with regard to the risk for overt stroke or SCI in SCA children.
Importantly, 6-month-old SS mice did not exhibit proliferative or stenotic changes in carotid arteries like those implicated in overt stroke in SCA, 4, 5 despite increased sensitivity to tHI-induced mortality and infarct. Similarly, the link between overt stroke and large cerebral vessel pathology is far from absolute in human SCA because Rothman et al 5 identified large-vessel intimal lesions at autopsy in only half of cerebral infarcts from older SCA patients (averaged 21.3 years of age at death versus 12.2 years of age in vascular pathology-free patients). Further, as many as 31% of stroke patients in the SWiTCH trial (Stroke With Transfusion Changing to Hydroxyurea) were negative for vascular stenosis on magnetic resonance angiography, despite a higher flow velocity on transcranial Doppler. 29 Hence, the progression of sickle cell vasculopathy and stroke complications may be viewed as a continuum of injury resulting from an imbalance between oxygen demand and supply in the context of cerebral blood flow that is already maximized by compensatory mechanisms ( Figure 4D) . 30 Such imbalance can be precipitated by a variety of events that increase oxygen demand (eg, fever) or reduce oxygen delivery (eg, hypoxia, ischemia, exacerbation of anemia, and large-vessel stenosis). Viewed in this light, our stroke models recapitulate the hypoxic-ischemic events that may produce large or smaller infarct depending on the severity of insults and the age of sickle mice.
Although SS mice did not reproduce proliferative vasculopathy identified previously in SCA patients, they showed endothelial activation (eg, P-selectin expression) and enhanced leukocyte-endothelium interactions, especially after tHI insults. This finding, together with the recent report of anti-P-selectin antibody attenuating painful crisis in SCA patients, 23 suggests the possibility that P-selectin antagonist might have a role in sickle stroke therapy. Moreover, we showed ectopic PAI-1 expression in cerebral blood vessels in SS mice, consistent with the reported induction of this procoagulant factor in pulmonary endothelial cells. 22 Our data suggest that proadhesive, procoagulant endothelial activation occurs in the cerebral vasculature, which may contribute to higher sensitivity to tHI-induced infarction and mortality in SS mice. Of note, a limitation of our study is the high mortality rate of sickle mice in rmHI or tHI stroke, which is consistent with the behaviors of sickle mice in the focal photothrombosis model (40% mortality in sickle mice compared with no death in stroked wild-type mice), 11 presumably because of the fragility of these mutant mice. We cannot exclude the possibility that tHI may also induce thrombosis in other organs (eg, pulmonary embolism) to contribute to greater mortality in SS mice.
Nonetheless, a key finding of this study is that tPA treatment attenuates tHI-induced cerebral perfusion deficits and mortality in SS mice, suggesting the possibility that lytic therapy may benefit SCA patients with acute ischemic stroke. Although thrombolysis is a mainstay in acute treatment of stroke because of atherosclerosis and embolic events, there has been reluctance to adopt this therapy in SCA stroke because of concerns of cerebral hemorrhage from aneurysm or largevessel vasculopathy. For example, SCA was a safety exclusion criterion in the TIPS trial (Thrombolysis in Pediatric Stroke trial; NCT01591096). However, a recent analysis of the Get With The Guidelines-Stroke data indicated that coexistent sickle cell disease did not increase the incidence of cerebral hemorrhage after lytic stroke therapy (P=0.4502). 8 This finding, coupled with our preclinical data of tPA-mediated benefits in tHI stroke in sickle mice, highlights the need to carefully assess the effects of lytic stroke therapy in SCA, first in animal models, and then in patients.
Conclusions
Humanized sickle mice exhibit procoagulant vasculopathy and enhanced leukocyte and platelet adherence to vascular endothelium after HI insult but without evidence of proliferative stenosis in large cerebral vessels. Higher RI is an early ultrasonic marker for increased sensitivity to HI-induced stroke in sickle mice. Thrombolysis attenuates HI-triggered mortality and cerebral infarct in sickle mice. Further studies to test the effects of lytic stroke therapy in children with SCA warrant considerations.
